GB001 + Placebo

Phase 2Completed
0 watching 0 views this week Active
44
Hype Score

Development Stage

Pre-clinical
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Asthma

Conditions

Asthma

Trial Timeline

Oct 22, 2018 → Aug 18, 2020

About GB001 + Placebo

GB001 + Placebo is a phase 2 stage product being developed by Gossamer Bio for Asthma. The current trial status is completed. This product is registered under clinical trial identifier NCT03683576. Target conditions include Asthma.

Hype Score Breakdown

Clinical
17
Activity
12
Company
2
Novelty
5
Community
5

Clinical Trials (2)

NCT IDPhaseStatus
NCT03956862Phase 2Completed
NCT03683576Phase 2Completed